Opthea Competitors and Similar CompaniesClear all

Opthea's competitors and similar companies include Ocular Therapeutix.
Opthea
Opthea
Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases.
Ocular Therapeutix
Ocular Therapeutix
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Founding Date
Founding Date
2012
Founding Date
2006
Type
Type
Public
Type
Public
Tags
Locations
Locations
South Yarra, AU HQ
Toorak, AU
Locations
Bedford, US HQ
Bedford, US
Bedford, US
Employees
Employees
33
Employees
16740% increase
Valuation ($)
Valuation ($)
711.2 m
Valuation ($)
1.8 b

Financial

Revenue (est.)
Revenue (est.)
$25k (FY, 2025)
Revenue (est.)
$52m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$6.6m (FY, 2025)
Gross profit
Gross profit
$146k (FY, 2025)
Gross profit
$45.4m (FY, 2025)
Net income
Net income
($162.8m) (FY, 2025)
Net income
($265.9m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 67.6m
Total funding raised
$ 73.3m
For sources of this data, please see the company profile

View Company Profiles

Ocular Therapeutix
HQ
Bedford, US
Employees
167↑ 40% increase

Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.

View company